GSA CAPITAL PARTNERS LLP - IMMUNOVANT INC ownership

IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 191 filers reported holding IMMUNOVANT INC in Q3 2023. The put-call ratio across all filers is 2.28 and the average weighting 0.6%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of IMMUNOVANT INC
ValueSharesWeighting
Q2 2023$621
-99.9%
32,736
-65.6%
0.06%
-11.4%
Q3 2022$531,000
+242.6%
95,146
+139.0%
0.07%
+204.3%
Q2 2022$155,000
-55.2%
39,817
-2.1%
0.02%
-46.5%
Q4 2021$346,000
-50.9%
40,654
-49.9%
0.04%
-40.3%
Q3 2021$705,000
+195.0%
81,170
+1468.5%
0.07%
+84.6%
Q4 2020$239,0005,1750.04%
Other shareholders
IMMUNOVANT INC shareholders Q3 2023
NameSharesValueWeighting ↓
Alpine Global Management, LLC 3,000,200$26,072,0005.92%
MANGROVE PARTNERS IM, LLC 1,139,900$9,906,0000.89%
Eventide Asset Management 4,950,000$43,016,0000.57%
Ghost Tree Capital, LLC 200,000$1,738,0000.51%
WITTENBERG INVESTMENT MANAGEMENT, INC. 140,500$1,221,0000.47%
FRAZIER MANAGEMENT LLC 585,759$5,090,0000.41%
MANGROVE PARTNERS IM, LLC 500,000$4,345,0000.39%
EcoR1 Capital, LLC 1,140,819$9,914,0000.34%
BCK CAPITAL MANAGEMENT LP 53,459$465,0000.28%
PLATINUM INVESTMENT MANAGEMENT LTD 555,065$4,824,0000.14%
View complete list of IMMUNOVANT INC shareholders